Tenon Medical’s 10% owner bought 108,140 shares across 5 transactions at $2.92 to $4.92 per share and sold 125,925 shares across 3 transactions at $2.61 to $5.56. The investor relevance is the simultaneous purchase and sale activity, followed by reported ownership of 15,839 shares.
Key Highlights
- HRT FINANCIAL LP was reported to own 15,839 Tenon Medical shares after the transactions.
- Purchase transactions used code P, while sale transactions used code S, covering Sep 8 through Sep 10.
- The sale activity involved 125,925 shares across 3 transactions at $2.61 to $5.56 per share.
Tenon Medical, Inc. (NASDAQ: TNON) saw its 10% owner buy 108,140 shares at prices from $2.92 to $4.92 per share across 5 transactions. The same holder also sold 125,925 shares in 3 transactions, with sale prices ranging from $2.61 to $5.56 per share. The purchase and sale windows therefore overlapped.
Tenon Medical Activity Runs Both Ways
HRT FINANCIAL LP bought 108,140 shares at $2.92 to $4.92 per share, while sales covered 125,925 shares at $2.61 to $5.56 per share. Purchases were split across 5 transactions and sales across 3, leaving reported ownership at 15,839 shares after the activity.
FAQs
Q: How many Tenon Medical shares did HRT FINANCIAL LP buy?
A: HRT FINANCIAL LP bought 108,140 Tenon Medical shares across 5 transactions. The purchases were priced from $2.92 to $4.92 per share.
Q: What did Tenon Medical’s 10% owner sell?
A: HRT FINANCIAL LP sold 125,925 Tenon Medical shares across 3 transactions. Sale prices ranged from $2.61 to $5.56 per share.
Q: How many Tenon Medical shares did HRT FINANCIAL LP own afterward?
A: HRT FINANCIAL LP was reported to own 15,839 Tenon Medical shares after the transactions. The holder is identified as a 10% owner.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.